APA (7th ed.) Citation

Fort, R. S., Mathó, C., Geraldo, M. V., Ottati, M. C., Yamashita, A. S., Saito, K. C., . . . Duhagon, M. A. (2018). Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. BMC Cancer, 18, 1. https://doi.org/10.1186/s12885-018-4049-7

Chicago Style (17th ed.) Citation

Fort, Rafael Sebastián, et al. "Nc886 Is Epigenetically Repressed in Prostate Cancer and Acts as a Tumor Suppressor Through the Inhibition of Cell Growth." BMC Cancer 18 (2018): 1. https://doi.org/10.1186/s12885-018-4049-7.

MLA (9th ed.) Citation

Fort, Rafael Sebastián, et al. "Nc886 Is Epigenetically Repressed in Prostate Cancer and Acts as a Tumor Suppressor Through the Inhibition of Cell Growth." BMC Cancer, vol. 18, 2018, p. 1, https://doi.org/10.1186/s12885-018-4049-7.